AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Breast Cancer Metastatic

A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast Cancer NCT05534438Phase 28 sites๐Ÿ“ Basking Ridge๐Ÿ“ Middletown๐Ÿ“ Montvale Memorial Sloan Kettering Cancer Center ยท Tests: Stereotactic body radiotherapy Access to Genetic Testing in Underserved Patients With Cancer NCT06422455NA2 sites๐Ÿ“ Los Angeles๐Ÿ“ Rochester University of Southern California ยท Tests: Best Practice, Educational Intervention, Electronic Health Record Review, Genetic Counseling, Interview A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment. NCT07062965Phase 3433 sites๐Ÿ“ Anchorage๐Ÿ“ Chandler๐Ÿ“ Gilbert Pfizer ยท Tests: PF-07248144, Fulvestrant, Everolimus, Exemestane CTCs in Breast Cancer After Neoadjuvant Treatment and Surgery: a Multicenter, Prospective Clinical Trial NCT05360290NA1 site๐Ÿ“ Shanghai RenJi Hospital ยท Tests: GILUPI CellCollectorยฎ Stereotactic Ablative Radiotherapy for OligoMetastatic Breast Cancer NCT05377047Phase 319 sites๐Ÿ“ Cork๐Ÿ“ Cork๐Ÿ“ Dublin Vastra Gotaland Region ยท Tests: SABR A Randomized Secondary Adjuvant Treatment Intervention Study Comparing Trastuzumab-Deruxtecan to SOC Therapy in eBC Patients With Molecular Relapse NCT06643585Phase 31 site๐Ÿ“ Ulm Prof. Wolfgang Janni ยท Tests: Trastuzumab-Deruxtecan, Physicians Choice (PhC). Novel MRI Techniques on Evaluation of Lymphedema NCT05804643n/a1 site๐Ÿ“ Taipei National Taiwan University Hospital ยท Tests: Diffusion magnetic resonance imaging Sensitivity of Organoids to Predict Treatment Outcome in Breast Cancer Metastases NCT06468124n/a2 sites๐Ÿ“ London๐Ÿ“ London King's College London Study on the Treatment of HER2-negative Breast Cancer Brain Metastases With Radiotherapy Combined With Anlotinib NCT07396454Phase 21 site๐Ÿ“ Nanjing The First Affiliated Hospital with Nanjing Medical Universiโ€ฆ ยท Tests: Radiotherapy Combined with Anlotinib and a Microtubule Inhibitor Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors NCT07288359Phase 1, Phase 216 sites๐Ÿ“ Atlanta๐Ÿ“ Nashville๐Ÿ“ San Antonio Novartis Pharmaceuticals ยท Tests: GVV858, Fulvestrant, Letrozole Efficacy of Trastuzumab Deruxtecan in Metastatic Breast Cancer With Different HER2 Expression Patterns NCT06551220n/a26 sites๐Ÿ“ New Haven๐Ÿ“ Boston๐Ÿ“ Fuzhou Sun Yat-sen University ยท Tests: Trastuzumab Deruxtecan Real-world Bicohort Observational Study of a Pertuzumab Biosimilar in the Treatment of Breast Cancer: in the Neoadjuvant Setting and in First-line Metastatic Disease NCT07542496n/a2 sites๐Ÿ“ Algiers๐Ÿ“ Algiers Sociรฉtรฉ Algรฉrienne de Formation et Recherche en Oncologie DiviTumยฎTKa: A Biomarker Assay for Efficacy in HR+ Breast Cancer Patients NCT06388122n/a1 site๐Ÿ“ Jacksonville Mayo Clinic ยท Tests: Biospecimen Collection PG2 Injection for the Treatment of moderate-to Severe Fatigue in Breast Cancer Patients NCT05440227Phase 21 site๐Ÿ“ Taipei PhytoHealth Corporation ยท Tests: PG2 Lyo. Injection 500mg, Placebo 0.9% normal saline Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors NCT05372640Phase 17 sites๐Ÿ“ Los Angeles๐Ÿ“ Los Angeles๐Ÿ“ Los Angeles National Cancer Institute (NCI) ยท Tests: Abemaciclib, BET Bromodomain Inhibitor ZEN-3694, Biopsy Procedure, Biospecimen Collection, Diagnostic Imaging Testing Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity NCT04273061Phase 22 sites๐Ÿ“ Vancouver๐Ÿ“ Toronto British Columbia Cancer Agency ยท Tests: Atezolizumab A Study on the Efficacy and Safety of Switching Between Two Targeted Strategies, HP+Chemotherapy and HPy+Chemotherapy, After Treatment Progression in HER-2 Positive Advanced or Metastatic Breast Cancer NCT07455188n/a1 site๐Ÿ“ Zhejiang Zhejiang Cancer Hospital ยท Tests: Antitumor treatment plan SRS & Abemaciclib w/wo Imlunestrant in the Management of HR+/HER2- Breast CA Brain Metastases NCT04923542Phase 1, Phase 22 sites๐Ÿ“ Tampa๐Ÿ“ Columbus H. Lee Moffitt Cancer Center and Research Institute ยท Tests: Stereotactic Radiosurgery (SRS), Abemaciclib, Endocrine therapy A Prospective, Open-label, Single-arm, Exploratory Clinical Trial to Evaluate the Safety and Tolerability of 225Ac-TR2205 Injection in Patients With Triple-negative Breast Cancer. NCT07340424EARLY Phase 11 site๐Ÿ“ Jinan Xiaorong Sun ยท Tests: 225Ac-TR2205 Injection FIH Study of RGT-419B Alone and With Endocrine Therapy in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer NCT05304962Phase 18 sites๐Ÿ“ La Jolla๐Ÿ“ Los Angeles๐Ÿ“ Port Saint Lucie Regor Pharmaceuticals Inc. ยท Tests: RGT-419B, RGT-419B in combination with hormonal therapy Tumor-Targeted-NIR-II Fluorescent Molecular Probes for the Identification of Breast Cancer Tissue and SLN Metastatic Status NCT06713161n/a1 site๐Ÿ“ Kunming Yunnan Cancer Hospital ยท Tests: NIR-II Probe(i.e ICG-POL6326) incubation solution Leuprolide and Goserelin for Ovarian Function Suppression in Pre- or Peri-menopausal Women With Breast Cancer, OFS Trial NCT07158021Phase 21 site๐Ÿ“ Ann Arbor University of Michigan Rogel Cancer Center ยท Tests: Biospecimen Collection, Electronic Health Record Review, Goserelin, Leuprolide, Questionnaire Administration A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02) NCT06330064Phase 1, Phase 2120 sites๐Ÿ“ Los Angeles๐Ÿ“ Los Angeles๐Ÿ“ Whittier Daiichi Sankyo ยท Tests: Ifinatamab deruxtecan SURVEY-CNS: A Feasibility Study of Randomising Women and Men With HER2-Positive Metastatic Breast Cancer to Central Nervous System Surveillance Versus No Surveillance NCT07503717NA1 site๐Ÿ“ Beaumont Royal College of Surgeons, Ireland ยท Tests: Brain Magnetic Resonance Imaging (MRI) with Contrast Breast Cancer Proteomics and Molecular Heterogeneity NCT01840293n/a6 sites๐Ÿ“ Cork๐Ÿ“ Dublin๐Ÿ“ Dublin Cancer Trials Ireland Study of BEBT-209 in Combination With Fulvestrant Versus Placebo in Combination With Fulvestrant in Patients With HR+/HER2- Locally Advanced or Metastatic Breast Cancer Who Have Progressed After Prior Endocrine Therapy NCT06998108Phase 31 site๐Ÿ“ Beijing BeBetter Med Inc ยท Tests: BEBT-209 capsules, BEBT-209 Placebo capluses, Fulvestrant Injection ARX788 in HER2-positive Metastatic Breast Cancer Patients NCT06663748Phase 21 site๐Ÿ“ Zhengzhou Henan Cancer Hospital ยท Tests: ARX788 Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer NCT06982521Phase 3243 sites๐Ÿ“ Gilbert๐Ÿ“ Beverly Hills๐Ÿ“ Duarte Relay Therapeutics, Inc. ยท Tests: Zovegalisib, Capivasertib, Fulvestrant [18F]FTT Positron Emission Tomography for the Measurement of PARP Tumor Expression in Patients With Metastatic Breast Cancer NCT06502691Phase 1, Phase 21 site๐Ÿ“ Seattle University of Washington ยท Tests: Best Practice, Biopsy of Breast, Computed Tomography, Electronic Health Record Review, Fludeoxyglucose F-18 The COMPASSION Study NCT06507930NA1 site๐Ÿ“ Boston Dana-Farber Cancer Institute ยท Tests: Telehealth Hospice Visits
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy